One of the most studied CTC-based biomarkers in PCa is the AR splice variant 7 (AR-V7) that is the best described and most abundant AR splice variant characterized by the lack of the C-terminal androgen-binding domain, making it constitutively active as a transcription factor, regardless of androgen signaling [18, 19]. This evidence concerns the gene AR and posterior cortical atrophy.